Skip to main content

Emerging diseases and learnings from covid-19

Inquiry

In the last three decades, 75% of new diseases in humans have originated in animals, and ‘spillover events’ (when a pathogen jumps from an animal into a human) have increased in prevalence. The UK has recently experienced its largest-ever outbreak of avian flu, a virus found in wild and domesticated birds which is also capable of infecting humans.

The Science and Technology Committee recently held a follow-up session on its joint Report with the Health and Social Care Committee, Coronavirus: lessons learned to date, which heard updates on the progress Government has made in implementing recommendations made by the joint inquiry with the Health and Social Care Committee.  

The Committee is seeking to examine how the Government is applying lessons learned from the covid-19 pandemic, and which of these could be applied to prevent the emergence and spread of new emerging diseases with pandemic potential. The Committee is also seeking to examine the UK’s biosecurity framework and involvement in international biosecurity initiatives.

This inquiry is no longer accepting evidence

The deadline for submissions was Friday 31 March 2023.

Reports, special reports and government responses

No reports or special reports published.

Oral evidence transcripts

View all oral evidence transcripts
28 February 2024
Inquiry Emerging diseases and learnings from covid-19
Witnesses Nicola Newman (Managing Director at Berkshire and Surrey Pathology Service), and Sarah Brampton (Deputy Chief Executive at University Hospitals Plymouth NHS Trust)
Oral Evidence
24 January 2024
Inquiry Emerging diseases and learnings from covid-19
Witnesses Dr Sergio Carmona (Chief Medical Officer and Interim CEO at FIND), and Dr In-Kyu Yoon (Acting Executive Director of Vaccine Research & Development at CEPI)
Oral Evidence
24 January 2024
Inquiry Emerging diseases and learnings from covid-19
Witnesses Professor Sir Andrew Pollard (Director at Oxford Vaccine Group), and Dr Clive Dix (Chief Executive Officer at C4X Discovery)
Oral Evidence
Dr Clive Dix (CEO at C4X Discovery) (EMD0060)
Dr In-Kyu Yoon (Acting Executive Director, Research and Development at CEPI) (EMD0061)
David Kidney (Executive Director at West Midlands Health Technologies Cluster Organisation) (EMD0059)

Other publications

No other publications published.

Contact us

We can’t usually help you with an individual problem or a specific complaint.

  • Email: commonssitc@parliament.uk
  • Phone: 020 7219 5023 (general enquiries) |020 7219 0731 (media enquiries)
  • Address: Science, Innovation and Technology Committee, House of Commons, London, SW1A 0AA